Bempedoic Acid Cuts CV Risk in the Statin-Intolerant: CLEAR ...Middle East

Medscape - News
In top-line results, high-risk patients with statin intolerance taking the lipid-lowering agent showed a significant decline in risk for CV events in the trial with more than 14,000 patients. Medscape Medical News

Hence then, the article about bempedoic acid cuts cv risk in the statin intolerant clear was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bempedoic Acid Cuts CV Risk in the Statin-Intolerant: CLEAR )

Apple Storegoogle play

Last updated :

Also on site :



Latest News